TipRanks
Go Ultimate75% OFF

CDK ASSOCIATES, L.L.C. Insider Profile

4 Followers

CDK ASSOCIATES, L.L.C., former Director at Molecular Templates, holds 8.06M shares in Strongbridge Biopharma (Ticker: SBBP), holds 1.58M shares in Molecular Templates (Ticker: MTEMQ). Most recently, CDK ASSOCIATES, L.L.C. Bought ― shares of Strongbridge Biopharma on Sep 21, 2020 for an estimated value of $3.33M.

CDK ASSOCIATES, L.L.C.'s Trading History

SBBP
Strongbridge Biopharma
Sep 21, 2020―Informative Buy3.33M$16.12M
MTEMQ
Molecular Templates
Dec 28, 2018―Informative Buy86.25K$45.94K

You May Also Like

CDK ASSOCIATES, L.L.C. insider profile FAQ

What is the percentage of profitable transactions made by CDK ASSOCIATES, L.L.C.?
The percentage of profitable transactions made by CDK ASSOCIATES, L.L.C. is 11%.
What is the average return per transaction made by CDK ASSOCIATES, L.L.C.?
The average return per transaction made by CDK ASSOCIATES, L.L.C. is -6.30%.
What stocks does CDK ASSOCIATES, L.L.C. hold?
CDK ASSOCIATES, L.L.C. holds: MTEMQ, SBBP stocks.
What was CDK ASSOCIATES, L.L.C.’s latest transaction?
CDK ASSOCIATES, L.L.C.’s latest transaction was an Informative Buy of $3.33M.
What was CDK ASSOCIATES, L.L.C.'s most profitable transaction?
CDK ASSOCIATES, L.L.C.’s most profitable transaction was an Informative Buy of MTEMQ stock on December 28, 2018. The return on the trade was 287.50%.
What is CDK ASSOCIATES, L.L.C.'s role in Molecular Templates?
CDK ASSOCIATES, L.L.C.'s role in Molecular Templates is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.